Benatar T - Search Results

1

Supplementation-dependent differences in the rates of embryonic stem cell self-renewal, differentiation, and apoptosis.

Viswanathan S, Benatar T, Mileikovsky M, Lauffenburger DA, Nagy A, Zandstra PW. Viswanathan S, et al. Among authors: benatar t. Biotechnol Bioeng. 2003 Dec 5;84(5):505-17. doi: 10.1002/bit.10799. Biotechnol Bioeng. 2003. PMID: 14574685

2

Ligand/receptor signaling threshold (LIST) model accounts for gp130-mediated embryonic stem cell self-renewal responses to LIF and HIL-6.

Viswanathan S, Benatar T, Rose-John S, Lauffenburger DA, Zandstra PW. Viswanathan S, et al. Among authors: benatar t. Stem Cells. 2002;20(2):119-38. doi: 10.1634/stemcells.20-2-119. Stem Cells. 2002. PMID: 11897869

3

Virulizin, a novel immunotherapy agent, stimulates TNFalpha expression in monocytes/macrophages in vitro and in vivo.

Li H, Cao MY, Lee Y, Benatar T, Lee V, Feng N, Gu X, Liu P, Jin H, Wang M, Der S, Lightfoot J, Wright JA, Young AH. Li H, et al. Among authors: benatar t. Int Immunopharmacol. 2007 Oct;7(10):1350-9. doi: 10.1016/j.intimp.2007.06.001. Epub 2007 Jun 26. Int Immunopharmacol. 2007. PMID: 17673150

4

Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.

Amemiya Y, Yang W, Benatar T, Nofech-Mozes S, Yee A, Kahn H, Holloway C, Seth A. Amemiya Y, et al. Among authors: benatar t. Breast Cancer Res Treat. 2011 Apr;126(2):373-84. doi: 10.1007/s10549-010-0921-0. Epub 2010 May 13. Breast Cancer Res Treat. 2011. PMID: 20464481

5

IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors.

Evdokimova V, Tognon CE, Benatar T, Yang W, Krutikov K, Pollak M, Sorensen PH, Seth A. Evdokimova V, et al. Among authors: benatar t. Sci Signal. 2012 Dec 18;5(255):ra92. doi: 10.1126/scisignal.2003184. Sci Signal. 2012. PMID: 23250396

6

IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways.

Benatar T, Yang W, Amemiya Y, Evdokimova V, Kahn H, Holloway C, Seth A. Benatar T, et al. Breast Cancer Res Treat. 2012 Jun;133(2):563-73. doi: 10.1007/s10549-011-1816-4. Epub 2011 Oct 14. Breast Cancer Res Treat. 2012. PMID: 21997538

7

Identification of a Novel MicroRNA Panel Associated with Metastasis Following Radical Prostatectomy for Prostate Cancer.

Nam RK, Wallis CJD, Amemiya Y, Benatar T, Seth A. Nam RK, et al. Among authors: benatar t. Anticancer Res. 2018 Sep;38(9):5027-5034. doi: 10.21873/anticanres.12821. Anticancer Res. 2018. PMID: 30194146

8

IL-17E, a proinflammatory cytokine, has antitumor efficacy against several tumor types in vivo.

Benatar T, Cao MY, Lee Y, Lightfoot J, Feng N, Gu X, Lee V, Jin H, Wang M, Wright JA, Young AH. Benatar T, et al. Cancer Immunol Immunother. 2010 Jun;59(6):805-17. doi: 10.1007/s00262-009-0802-8. Epub 2009 Dec 13. Cancer Immunol Immunother. 2010. PMID: 20012860

9

Virulizin induces production of IL-17E to enhance antitumor activity by recruitment of eosinophils into tumors.

Benatar T, Cao MY, Lee Y, Li H, Feng N, Gu X, Lee V, Jin H, Wang M, Der S, Lightfoot J, Wright JA, Young AH. Benatar T, et al. Cancer Immunol Immunother. 2008 Dec;57(12):1757-69. doi: 10.1007/s00262-008-0502-9. Epub 2008 Mar 20. Cancer Immunol Immunother. 2008. PMID: 18351336

10

Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages.

Li H, Cao MY, Lee Y, Lee V, Feng N, Benatar T, Jin H, Wang M, Der S, Wright JA, Young AH. Li H, et al. Among authors: benatar t. Cancer Immunol Immunother. 2005 Nov;54(11):1115-26. doi: 10.1007/s00262-005-0698-x. Epub 2005 May 13. Cancer Immunol Immunother. 2005. PMID: 15891881

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results